Jim Olson is a member of the Clinical Research Division of the Fred Hutchinson Cancer Research Center, a professor of pediatric hematology and oncology at the University of Washington, and an attending physician at Seattle Children's. He's the founder of two Seattle biotech companies, Presage Biosciences and Blaze Bioscience. Dr. Olson discovers and develops promising new drugs for cancer patients. He cares for children with brain cancer, and much of his work is focused on them.
© 2007-2018, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.